IRF6 and neuroblastoma: Kaplan‒Meier survival analysis revealed that low IRF6 expression was associated with a poor overall and event-free survival in neuroblastoma patients, based on the GSE16476 and Cangelosi786 datasets (Fig. 1B, C).